Los Angeles Capital Management’s Integra LifeSciences IART Stock Holding History

Los Angeles Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.56K	Hold	378	–	–	﹤0.01%	2208
2025 Q4	$4.46K	Buy	+378	New	+$5.03K	﹤0.01%	2302
2019 Q4	–	Sell	-8,848	Closed	-$531K	–	1303
2019 Q3	$531K	Sell	8,848 -1,420	-14%	-$84.6K	﹤0.01%	970
2019 Q2	$573K	Buy	10,268 +2,190	+27%	+$113K	﹤0.01%	1003
2019 Q1	$450K	Buy	+8,078	New	+$411K	﹤0.01%	1112
2018 Q4	–	Sell	-9,348	Closed	-$616K	–	1321
2018 Q3	$616K	Buy	9,348 +1,930	+26%	+$120K	﹤0.01%	1045
2018 Q2	$478K	Buy	7,418 +2,600	+54%	+$161K	﹤0.01%	1148
2018 Q1	$267K	Hold	4,818	–	–	﹤0.01%	1199
2017 Q4	$231K	Sell	4,818 -270	-5%	-$13.2K	﹤0.01%	1237
2017 Q3	$257K	Buy	5,088 +830	+19%	+$42.6K	﹤0.01%	1188
2017 Q2	$232K	Buy	+4,258	New	+$203K	﹤0.01%	1130
2014 Q3	–	Sell	-13,578	Closed	-$261K	–	1116
2014 Q2	$261K	Hold	13,578	–	–	﹤0.01%	1068
2014 Q1	$255K	Hold	13,578	–	–	﹤0.01%	1115
2013 Q4	$265K	Buy	+13,578	New	+$249K	﹤0.01%	1118

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Los Angeles Capital Management's IART Position: Q1 2026 in Review

Los Angeles Capital Management held its Integra LifeSciences (IART) position steady in Q1 2026 at 378 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2208.

Los Angeles Capital Management first reported a position in IART in Q4 2013 and has held it in 14 quarters since. The position peaked at $616K in Q3 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Los Angeles Capital Management held 378 shares of Integra LifeSciences worth $3.56K as of Q1 2026.
Los Angeles Capital Management left its Integra LifeSciences share count unchanged in Q1 2026.
Integra LifeSciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #2208 holding.
Los Angeles Capital Management first reported a position in Integra LifeSciences in Q4 2013 and has held it in 14 quarters since.
Los Angeles Capital Management's Integra LifeSciences position peaked at $616K in Q3 2018.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.